Ligand validation:4C3A

Q16: 6-((((3S, 5R)-5-(((6-amino-4-methylpyridin-2-yl)methoxy)methyl)pyrrolidin-3-yl)oxy)methyl)-4-methylpyridin-2-amine

Q16 is a Ligand Of Interest in 4C3A designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4C3A_Q16_A_800	59%	43%	0.126	0.908	0.84	1.37	-	5	2	0	100%	1
4C3A_Q16_B_800	53%	36%	0.141	0.902	0.68	1.79	-	6	1	0	100%	1
4CX0_Q16_A_800	85%	43%	0.08	0.943	0.78	1.39	-	4	0	0	100%	1
4D1P_Q16_B_800	48%	39%	0.169	0.912	0.39	1.96	-	9	2	0	100%	1
4CX6_Q16_B_800	52%	25%	0.158	0.917	0.75	2.26	-	13	1	0	100%	1
4UGF_Q16_A_904	52%	37%	0.143	0.901	0.51	1.93	-	11	4	0	100%	1
4C39_Q16_B_800	46%	22%	0.195	0.933	0.86	2.36	1	10	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.